Integral Metals Corp. (the "Company" or "Integral") is pleased to provide a year-in-review summary of exploration activities completed in 2025, along with an outlook on planned technical work and ...

NAYA's European Hub to Accelerate Clinical Development of its Astatine-211 Targeted Alpha Therapies and Multispecific Antibodies MIAMI, FL AND PARIS, FRANCE / ACCESS Newswire / January 7, 2026 / NAYA ...

Gifthealth, a unified digital pharmacy platform, today celebrated the grand opening of its state-of-the-art pharmacy located in Mesa, Arizona. The new ...

It was a tight contest in Cape Town, with neither team scoring until the 30th minute, when Springboks No.10 Handre Pollard ...

(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...

The deal concerns the connectivity between Glooko's self-titled mobile app and Dexcom's continuous glucose monitoring (CGM) devices. Currently, Dexcom device users upload CGM data to the Glooko app ...

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...

DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...

News headlines Dexcom has entered a new phase of innovation under CEO Jake Leach, focusing on personalized health technology. Despite a challenging year for stock performance, analysts highlight ...

The Round of 16 race is heating up as Leinster, UBB, Bristol, Glasgow and others clinch places while the final pool games ...